Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.44 |
| ▸ | PDE7A | Q13946 | 3/20 | 0.43 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29438693 | 1.00 | ALDH1A1 (0.54) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL10857430 | 0.82 | ALDH1A1 (0.52) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL985995 | 0.82 | AHR (0.51) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL15529688 | 0.82 | ALDH1A1 (0.52) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL29780392 | 0.82 | AHR (0.51) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL1038613 | 0.80 | ALDH1A1 (0.50) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL1303639 | 0.80 | ALDH1A1 (0.50) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL3345475 | 0.80 | ALDH1A1 (0.50) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL1162908 | 0.80 | ALDH1A1 (0.57) | ALDH1A1HSD17B10LMNATDP1MAPT | |
| SCHEMBL31143401 | 0.80 | ALDH1A1 (0.47) | ALDH1A1LMNATDP1MAPTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 541 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115433121-B | Synthetic method of aliphatic diamine monomer for preparing transparent polyimide | 东南大学 | 2023-11-28 | — | — | CN | claimed |
| CN-115433121-A | Synthetic method of aliphatic diamine monomer for preparing transparent polyimide | 东南大学 | 2022-12-06 | — | — | CN | claimed |
| CN-112142654-A | Aromatic diamine monomer containing fluorene group and pyridine heterocyclic structure and preparation method and application thereof | 东华大学 | 2020-12-29 | — | — | CN | claimed |
| US-20260125381-A1 | NOVEL Kv3 CHANNEL MODULATORS | MERCK SHARP & DOHME LLC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260078127-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | BOEHRINGER INGELHEIM INT (DE) | 2026-03-19 | — | — | US | disclosed |
| US-20260049085-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | SCHRÖDINGER, INC. (US) | 2026-02-19 | — | — | US | disclosed |
| US-20250276983-A1 | COMPOUNDS AND METHODS FOR MODULATING HER2 | IAMBIC THERAPEUTICS, INC. | 2025-09-04 | — | — | US | disclosed |
| US-12404260-B2 | Pyridine rings containing derivatives as MALT1 inhibitors | JANSSEN PHARMACEUTICA NV (BE) | 2025-09-02 | — | — | US | disclosed |
| EP-4604945-A2 | NOVEL KV3 CHANNEL MODULATORS | Merck Sharp & Dohme LLC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12398146-B2 | Heterobicyclic amides as inhibitors of CD38 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2025-08-26 | — | — | US | disclosed |
| US-20250241300-A1 | AGRICULTURAL COMPOSITIONS FOR IMPROVED CROP PRODUCTIVITY AND ENHANCED PHENOTYPES | SPOGEN BIOTECH INC. | 2025-07-31 | — | — | US | disclosed |
| US-4548888-A | DIFFUSION TRANSFER | EASTMAN KODAK COMPANY (US) | 1985-10-22 | — | — | US | disclosed |
| US-4540578-A | Pesticidal phenoxypyridyl benzoyl ureas | UNION CARBIDE CORPORATION (US) | 1985-09-10 | — | — | US | disclosed |
| EP-0147105-A2 | Photographic products employing novel nondiffusible hydrazone dye-releasing compounds | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1985-07-03 | — | — | EP | disclosed |
| EP-0113247-A1 | Pesticidal phenoxyphenyl and phenoxypyridyl benzoyl ureas and process for their preparation | UNION CARBIDE CORPORATION (US) | 1984-07-11 | — | — | EP | disclosed |
| US-4441913-A | PRE- AND POST-EMERGENCE | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-04-10 | — | — | US | disclosed |
| EP-0029123-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ANILINES, AND SUBSTITUTED ANILINES | BASF Aktiengesellschaft (DE) | 1983-06-08 | — | — | EP | disclosed |
| EP-0068260-A2 | Substituted phenoxypropionates, process for their preparation and their use as herbicides | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1983-01-05 | — | — | EP | disclosed |
| EP-0029123-A1 | Process for the preparation of substituted anilines, and substituted anilines | BASF Aktiengesellschaft (DE) | 1981-05-27 | — | — | EP | disclosed |
| US-4149872-A | N-pyridinyl urea and cyclopropanecarboxamide herbicides | SHELL OIL COMPANY (US) | 1979-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398146-B2 | Heterobicyclic amides as inhibitors of CD38 | CD38, PARP12, ENTPD2 | ALDH1A1 361/4885HSD17B10 1410/4885LMNA 1943/4885 |
| US-20260078127-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | CD38, CD22, CD79B | ALDH1A1 877/4885HSD17B10 610/4885LMNA 2393/4885 |
| US-20260125381-A1 | NOVEL Kv3 CHANNEL MODULATORS | KCNN3, KCNA3, KCNQ3 | ALDH1A1 3929/4885HSD17B10 3444/4885LMNA 2236/4885 |
| US-12404260-B2 | Pyridine rings containing derivatives as MALT1 inhibitors | MALT1, SQSTM1, PPP3R1 | ALDH1A1 2124/4885HSD17B10 962/4885LMNA 3517/4885 |
| US-20260049085-A1 | CYCLIC COMPOUNDS AND METHODS OF USING SAME | CCR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, MALT1 | ALDH1A1 2214/4885HSD17B10 366/4885LMNA 1006/4885 |
| US-20250276983-A1 | COMPOUNDS AND METHODS FOR MODULATING HER2 | ERBB2, EGFR, ERBB3 | ALDH1A1 2783/4885HSD17B10 3425/4885LMNA 2503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.